Skip to content

Multicenter Evaluation of Patients Using LATITUDE Monitoring System

Multicenter Evaluation of Patients Using LATITUDE Monitoring System: Multitude Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06311149
Acronym
Multitude
Enrollment
20000
Registered
2024-03-15
Start date
2023-12-01
Completion date
2043-12-31
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac, Cardiovascular Diseases, Heart Failure, Sudden Cardiac Death

Keywords

Cardiac implantable electrical device, Implantable cardioverter defibrillator, Pacemaker, Cardiac resynchronization therapy, Subcutaneous defibrillator, Implantable cardiac monitor, Remote monitoring, Latitude monitoring system

Brief summary

The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database. The registry is designed to constitute a shared environment for the collection, management, analysis and reporting of clinical and diagnostic data, adopted by a network of European scientifically-motivated physicians who use rhythm management diagnostic and therapeutic solutions from Boston Scientific in their clinical practice. The Multitude study will facilitate the sharing of scientific proposals within a large network of researchers, and it will allow researchers to record the experience with medical devices throughout the device and patient lifecycle.

Interventions

None listed

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject is willing and capable of providing informed consent to collect/store/process personal health information by the sponsor or such consent is provided by a legally designated representative, if required by local law or regulation. * Subject is: 1. prospectively scheduled for receiving a device monitored through the LATITUDE monitoring system 2. retrospectively enrolled after having received a device monitored through the LATITUDE monitoring system

Exclusion criteria

* Subject foreseen not to be followed at the enrolling center for at least 1 year after having received the device. * Subject is receiving a device that is not approved for commercial use at the time of procedure.

Design outcomes

Primary

MeasureTime frameDescription
Mortality10 yearsMortality

Secondary

MeasureTime frameDescription
Hospitalization10 yearsHospitalization
Device therapy10 yearsFor therapeutic devices, e.g. ICDs, CRT-Ds, S-ICDs)
Device-related complications10 yearsComplication

Countries

Italy

Contacts

Primary ContactMatteo Bertini, Prof
doc.matber@gmail.com+390532236111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026